Link Pharma Chem (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Link Pharma Chem Limited |
|||
|
Price: ₹42.49 | ||
| 52 Week Low: ₹39.10 52 Week High: ₹55.71 |
|||
| Market Capital: 18 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Link Pharma Chem Share Price Target For 2024
- 1.1.1: Link Pharma Chem Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Link Pharma Chem Share Price Target For 2025
- 1.2.1: Link Pharma Chem Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Link Pharma Chem Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Link Pharma Chem Financial Performance
- 3.0.1: Is Link Pharma Chem A Good Buy For Long Term?
To predict the Link Pharma Chem's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Link Pharma Chem Share Price Target For 2024
The line chart displays the monthly closing prices of Link Pharma Chem with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Link Pharma Chem shares in 2024, see the table below.
Link Pharma Chem Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 44.05 (+3.67%) | Price Action: 14 Jul 2023 Low |
| 2024 Target 2 | 43.6 (+2.61%) | Price Action: 25 Oct 2023 Low |
| 2024 Target 1 | 43.16 (+1.57%) | Price Action: 11 Oct 2023 Low |
| Current Price | 42.49 | Link Pharma Chem's share price as of 26 Dec 2024 |
| Stop Loss 1 | 42.15 (-0.81%) | Price Action: 04 Dec 2024 High |
| Stop Loss 2 | 41.71 (-1.84%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 3 | 41.26 (-2.9%) | Price Action: 09 Dec 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Link Pharma Chem is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹41.52 serves as the nearest technical reference point.
Historical Returns: 3-month: +2.14% | 6-month: -7.02% | 1-year: -4.01%
Link Pharma Chem Share Price Target For 2025
The line chart displays the monthly closing prices of Link Pharma Chem with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Link Pharma Chem shares in 2025, see the table below.
Link Pharma Chem Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 53.99 (+27.06%) | Price Action: 25 Aug 2023 High |
| 2025 Target 2 | 53.27 (+25.37%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 52.49 (+23.53%) | Price Action: 22 Aug 2023 High |
| Current Price | 42.49 | Link Pharma Chem's share price as of 26 Dec 2024 |
| Stop Loss 1 | 40.0 (-5.87%) | Price Action: Jun 2021 High |
| Stop Loss 2 | 39.5 (-7.04%) | Price Action: 04 Jun 2024 Low |
| Stop Loss 3 | 39.1 (-7.98%) | Price Action: Jun 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Link Pharma Chem is currently trading near its 52-week low of ₹39.1, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -4.01% | 3-year: -21.39% | 5-year: +245.45%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Link Pharma Chem Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹42.49 | ||
| 2024 | ₹39.53 | -6.96% | ₹40.12 |
| 2025 | ₹36.61 | -7.38% | ₹39.25 |
| 2026 | ₹30.46 | -16.79% | ₹36.96 |
| 2027 | ₹27.09 | -11.06% | ₹31.23 |
| 2028 | ₹28.52 | +5.27% | ₹28.95 |
| 2029 | ₹32.17 | +12.79% | ₹34.87 |
| 2030 | ₹31.52 | -2.02% | ₹32.48 |
| 2031 | ₹27.87 | -11.57% | ₹32.25 |
| 2032 | ₹37.30 | +33.83% | ₹37.86 |
| 2033 | ₹36.49 | -2.17% | ₹42.58 |
| 2034 | ₹34.93 | -4.27% | ₹42.27 |
| 2035 | ₹35.86 | +2.66% | ₹41.48 |
| 2036 | ₹32.83 | -8.44% | ₹36.53 |
| 2037 | ₹33.11 | +0.85% | ₹40.44 |
| 2038 | ₹32.29 | -2.47% | ₹41.42 |
| 2039 | ₹41.11 | +27.31% | ₹41.73 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Link Pharma Chem Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 18 Crore | Market valuation of Link Pharma Chem's shares. |
| Revenue (TTM) | 29.89 Crore | Total revenue generated by Link Pharma Chem over the past twelve months. |
| Net Income (TTM) | -1.36 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -3.5% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +44.2% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+10.13% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.67 | Company's total debt divided by total shareholder equity. |
| Total Debt | 9.22 Crore | Sum of Link Pharma Chem's current & long-term financial obligations. |
Is Link Pharma Chem A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
